By: Kay Quinn, Healthbeat Reporter 11 October 2010 St. Louis, MO (KSDK) — A year from now, babies could be getting a higher dose of flu vaccine than they’ll get this fall. The National Institutes of Health (NIH) is supporting a nation-wide infant flu vaccine study, which will include at least two dozen St. Louis […]
BARDA awards contracts for influenza vaccine
By: Paul Purlain 11 October 2010 The U.S. Department of Health and Human Services’ Biomedical Advanced Research Development Authority has announced a new contract worth $57 million to help safeguard the United States in the case of a pandemic influenza outbreak. The contract with French pharmaceutical company Sanofi Pasteur is an extension of an existing […]
The 2009 H1N1 Pandemic Influenza Virus: What Next?
By: David M. Morgan, et al; National Institute of Allergy and Infectious Diseases 28 September 2010 Abstract: History suggests that the 2009 pandemic H1N1 influenza virus faces extinction unless it mutates to avoid already high global population immunity. The immune escape mechanisms potentially at its disposal include antigenic drift, antigenic shift via genetic reassortment, and […]
FDA: Gardasil approved to prevent anal cancer
FDA Press Release 22 December 2010 The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years. Gardasil is already approved for the same age […]
Gardasil, the FDA, and VAERS: How Americans concerned about vaccines interact with government
By: Marci Greenstein 14 December 2010 Emily Tarsell thought she had enough information about Gardasil — a new vaccine marketed to girls to prevent certain types of cervical cancer — when she agreed to have her daughter receive the vaccine. But after her third and last injection of Gardasil, in 2008, Christina Tarsell, […]
